The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s gastrointestinal bleeding treatment devices market report forecasts the gastrointestinal bleeding treatment devices market size to grow to $1.03 Billion by 2027, with a CAGR (compound annual growth rate) of more than 5%.

Learn More On The Gastrointestinal Bleeding Treatment Devices Market Report 2023 – https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

Gastrointestinal Bleeding Treatment Devices Market Size Forecast
The global gastrointestinal bleeding treatment devices market is expected to grow from $0.78 billion in 2022 to $0.83 billion in 2023 at a compound annual growth rate (CAGR) of 6.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The gastrointestinal bleeding treatment devices market size is expected to grow to $1.03 billion in 2027 at a CAGR of 5.6%.

North America held the largest gastrointestinal bleeding treatment devices market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Gastrointestinal Bleeding Treatment Devices Market Driver ­– Rise In The Incidences Of Upper Gastrointestinal Bleeding
For instance, according to the National Institute for Health and Care Excellence, in the UK the incidence of acute upper GI bleeding ranges from 84-172 per 100,000 of the population per year. Furthermore, as per the study published by the International Journal of Surgery Global Health in May 2020, the incidence of acute upper GI bleeding in the Western world recorded to be 103 cases per 100,000 adults annually. Therefore, the rise in the incidences of upper gastrointestinal bleeding propels the growth of the gastrointestinal bleeding treatment devices market.

Request for A Sample Of The Global Gastrointestinal Bleeding Treatment Devices Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5307&type=smp

Key Gastrointestinal Bleeding Treatment Devices Market Trend – Increasing Number Of Product Approvals
Key players in the market are focusing on product approvals to maintain a comparative advantage over competitors in the industry. For example, in February 2021, EndoClot Plus Inc., a US-based company developing medical devices to meet the needs of the GI professional announced U.S. Food and Drug Administration (FDA) approval for EndoClot Polysaccharide Hemostatic System (EndoClot PHS), which is an advanced product that will assist Gastroenterologists to stop bleeding quickly and effectively. EndoClot PHS is a one-time-use device that consists of a starch-based powder hemostat that is applied directly to the bleeding location using a flexible endoscope.

Gastrointestinal Bleeding Treatment Devices Market Segment
1) By Product: Endoscopic Thermal Devices, Other Products
2) By GI Tract Division: Upper GI Tract, Lower GI Tract
3) By End User: Hospitals Or Clinics, Ambulatory Surgical Centers, Other End-users

Gastrointestinal Bleeding Treatment Devices Market Major Players and Strategies
Major players in the gastrointestinal bleeding treatment devices market are CONMED, Boston Scientific Corporation, US Medical Innovations, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin GmbH, Steris PLC, and Pfizer Inc.

In January 2021, Olympus Corporation, a Japan-based company offering solutions for the effective treatment of gastrointestinal bleeding, announced a collaboration with Hitachi Ltd for five-year. Under this collaboration, the companies will work together to develop Endoscopic Ultrasound Systems (EUS), which are used to treat digestive diseases and assess the stage of cancer in the bronchus, liver, pancreas as well as in minimally invasive care, thereby contributing to medical treatment. Hitachi Ltd is a Japanese multinational conglomerate company offering gastrointestinal diagnoses solutions.

The Gastrointestinal Bleeding Treatment Devices Global Market Report 2023 covers regional data on gastrointestinal bleeding treatment devices market size, gastrointestinal bleeding treatment devices market trends and drivers, opportunities, strategies, and gastrointestinal bleeding treatment devices market competitor analysis. The countries covered in the gastrointestinal bleeding treatment devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Gastrointestinal (GI) bleeding is a sign of an illness in which the gastrointestinal system bleeds. The bleeding could occur anywhere in the gastrointestinal system, including the large intestine, anus, esophagus, small intestine, rectum, and stomach.

View More Reports Related To The Gastrointestinal Bleeding Treatment Devices Market –
Gastrointestinal Devices Global Market Report 2023
Bleeding Disorders Treatment Global Market Report 2023
Blood Transfusion Diagnostics Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: